Abstract
Lung cancer is the second most common cancer in the United States. Since therapeutic regimens target specific mutations, molecular testing has become routine practice. Molecular analysis is expensive and poses a burden on rising health care costs. The present study was undertaken to see if pathologic features are predictive of molecular alterations in lung cancers. A retrospective search of …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
